Shares Soar on First Day of Trading for China’s Nasdaq Rival

Executives from 25 tech companies gathered in Shanghai to celebrate the start of trading of China’s new stock board, which launched Monday morning. After a day of trading, it’s clear they had reason to celebrate; the companies listed on Shanghai Stock Exchange’s Sci-Tech Innovation Board (dubbed the Star Market), ranging from chipmakers to biotech businesses,…

Benchling, which provides software for managing biotech research, raises $34.5M Series C led by Menlo Ventures (Jonathan Shieber/TechCrunch)

Sponsor Posts Smartsheet: Gartner research vice president Mike Gotta to present at Smartsheet ENGAGE  —  Gotta will discuss why collaborative work management is increasingly essential for business at Smartsheet’s annual customer conference Sept. 30-Oct. 3 in Seattle. TWiT.tv: From Android to Zuckerberg – and everything in-between  —  Dig deep into tech news worth talking about. …

Why Achillion Pharmaceuticals Stock Is Soaring Again Today

The biotech stock is enjoying a second day of big gains after the company reported promising results for experimental drug ACH-5228. What happened Shares of Achillion Pharmaceuticals (NASDAQ:ACHN) were soaring 24.9% higher as of 11:16 a.m. EDT on Tuesday. This big move came after the biotech stock jumped more than 13% on Monday following Achillion’s…

What You’ll Want to Know About ImmunoGen’s Q2 Results

The clinical-stage biotech appears to be in solid financial shape as it moves toward a pivotal clinical study for its lead pipeline candidate. There wasn’t much to be thrilled about the last time ImmunoGen (NASDAQ:IMGN) announced its quarterly results in May. Revenue decreased. The biotech’s net loss worsened. But that’s old news. ImmunoGen announced its…

How Big Is Celgene’s Latest Good News?

FDA approval of fedratinib could lead to significantly more revenue for the biotech. But even better news could be on the way. After a couple of years of mainly bad news, Celgene (NASDAQ:CELG) is enjoying a streak of good news so far in 2019. The biotech won U.S. Food and Drug Administration (FDA) approval for…